Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Clin Exp Immunol ; 152(3): 538-41, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18422730

RESUMO

Cellular immunity with interferon gamma production could have a role in protection from hepatitis C virus (HCV). Interleukin (IL)-12 is a key cytokine in promoting such anti-viral T helper 1 (Th1) responses. We hypothesized that a genetic background able to promote cellular responses may be associated with apparent protection from infection and have investigated the distribution of the functional 1188A/C polymorphism of IL-12B in HCV exposed but uninfected cases. The frequency of the high IL-12-producing C allele was determined by restriction enzyme genotyping in 76 exposed-uninfected individuals and 105 healthy controls. Overall, the C allele was found in 27.6% of exposed-uninfected cases compared with 16.7% of healthy controls [chi(2) = 6.3, P = 0.02, odds ratio (OR) = 1.9, 95% confidence interval (CI) = 1.1-3.2]. CC genotype was found in 10.5% of exposed-uninfected cases compared with 0.9% controls (chi(2) = 9.3, P = 0.01, OR = 12, 95% CI = 1.5-100). Individuals at high risk of HCV infection yet who remain uninfected may be resistant in some way to infection. In our cohort of exposed-uninfected cases a genetic background of enhanced IL-12 production was associated with apparent resistance to HCV infection. This lends support to a central role for cellular immune responses in protecting from infection.


Assuntos
Hepatite C/genética , Hepatite C/prevenção & controle , Subunidade p40 da Interleucina-12/genética , Polimorfismo de Fragmento de Restrição , Adulto , Feminino , Frequência do Gene , Predisposição Genética para Doença , Genótipo , Hepatite C/imunologia , Hepatite C/transmissão , Hepatite C Crônica/genética , Hepatite C Crônica/imunologia , Hepatite C Crônica/transmissão , Humanos , Imunidade Celular , Imunidade Inata , Masculino , Abuso de Substâncias por Via Intravenosa/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA